Adjuvant therapy for true ampullary cancer: a systematic review View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2020-01-11

AUTHORS

M. Bonet, A. Rodrigo, S. Vázquez, V. Carrizo, F. Vilardell, M. Mira

ABSTRACT

BackgroundGiven the lack of evidence on the best adjuvant approach, this review closely examines optimal adjuvant management for resected true ampullary cancer and its histological subtypes.Materials and methodsA comprehensive literature search of PubMed was performed to identify studies on resected true ampullary cancers, published between January 2010 and December 2018. Data including the use of radiation, chemotherapy or chemoradiation and the outcomes were extracted.ResultsA total of 116 records were identified, of which 65 screened were selected. Finally, nine studies were included. Only two of the studies reported separately the outcomes of pancreatobiliary and intestinal subtypes. Patients in the selected studies were treated with a pancreaticoduodenectomy with negative margins. Patients treated with adjuvant therapy were more likely to be pT3-4 and have positive nodes; median survival ranged from 30 to 47 months. A significant benefit for adjuvant treatment was observed in four of the studies, restricted to patients at stage IIB or higher. Likewise, patients with positive nodes may have a longer median survival with adjuvant chemoradiation compared to observation.ConclusionsThe present review suggests a benefit for adjuvant treatment for patients with locally advanced tumors. Randomized trials are needed to ascertain the topic, as well as studies reporting toxicity and quality of life of resected true ampullary cancer patients. More... »

PAGES

1407-1413

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12094-019-02278-6

DOI

http://dx.doi.org/10.1007/s12094-019-02278-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1124031663

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/31927720


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ampulla of Vater", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Pancreatic Ductal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoradiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Common Bile Duct Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Duodenal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pancreaticoduodenectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonet", 
        "givenName": "M.", 
        "id": "sg:person.01057361501.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057361501.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Medical Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rodrigo", 
        "givenName": "A.", 
        "id": "sg:person.016462672040.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016462672040.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "V\u00e1zquez", 
        "givenName": "S.", 
        "id": "sg:person.013046075203.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013046075203.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.411443.7", 
          "name": [
            "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carrizo", 
        "givenName": "V.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut de Recerca Biom\u00e8dica de Lleida (IRB-Lleida), Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Department of Surgical Pathology, Hospital Universitari Arnau de Vilanova (HUAV), Lleida, Spain", 
            "Institut de Recerca Biom\u00e8dica de Lleida (IRB-Lleida), Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vilardell", 
        "givenName": "F.", 
        "id": "sg:person.0620130305.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620130305.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institut de Recerca Biom\u00e8dica de Lleida (IRB-Lleida), Lleida, Spain", 
          "id": "http://www.grid.ac/institutes/grid.420395.9", 
          "name": [
            "Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain", 
            "Institut de Recerca Biom\u00e8dica de Lleida (IRB-Lleida), Lleida, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mira", 
        "givenName": "M.", 
        "id": "sg:person.01234630226.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234630226.78"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11605-017-3624-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092633517", 
          "https://doi.org/10.1007/s11605-017-3624-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2015.172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011981731", 
          "https://doi.org/10.1038/bjc.2015.172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1748-717x-6-126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030603557", 
          "https://doi.org/10.1186/1748-717x-6-126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1245/s10434-011-2117-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046708404", 
          "https://doi.org/10.1245/s10434-011-2117-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-018-1849-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101294118", 
          "https://doi.org/10.1007/s12094-018-1849-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11605-011-1518-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040979791", 
          "https://doi.org/10.1007/s11605-011-1518-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-018-1832-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100403978", 
          "https://doi.org/10.1007/s12094-018-1832-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-01-11", 
    "datePublishedReg": "2020-01-11", 
    "description": "BackgroundGiven the lack of evidence on the best adjuvant approach, this review closely examines optimal adjuvant management for resected true ampullary cancer and its histological subtypes.Materials and methodsA comprehensive literature search of PubMed was performed to identify studies on resected true ampullary cancers, published between January 2010 and December 2018. Data including the use of radiation, chemotherapy or chemoradiation and the outcomes were extracted.ResultsA total of 116 records were identified, of which 65 screened were selected. Finally, nine studies were included. Only two of the studies reported separately the outcomes of pancreatobiliary and intestinal subtypes. Patients in the selected studies were treated with a pancreaticoduodenectomy with negative margins. Patients treated with adjuvant therapy were more likely to be pT3-4 and have positive nodes; median survival ranged from 30 to 47\u00a0months. A significant benefit for adjuvant treatment was observed in four of the studies, restricted to patients at stage IIB or higher. Likewise, patients with positive nodes may have a longer median survival with adjuvant chemoradiation compared to observation.ConclusionsThe present review suggests a benefit for adjuvant treatment for patients with locally advanced tumors. Randomized trials are needed to ascertain the topic, as well as studies reporting toxicity and quality of life of resected true ampullary cancer patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12094-019-02278-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035367", 
        "issn": [
          "1699-048X", 
          "1699-3055"
        ], 
        "name": "Clinical and Translational Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "ampullary cancer", 
      "adjuvant therapy", 
      "positive nodes", 
      "median survival", 
      "adjuvant treatment", 
      "methodsA comprehensive literature search", 
      "optimal adjuvant management", 
      "ampullary cancer patients", 
      "quality of life", 
      "comprehensive literature search", 
      "ConclusionsThe present review", 
      "adjuvant chemoradiation", 
      "lack of evidence", 
      "adjuvant management", 
      "adjuvant approach", 
      "pT3-4", 
      "stage IIB", 
      "randomized trials", 
      "histological subtypes", 
      "negative margins", 
      "advanced tumors", 
      "intestinal subtype", 
      "cancer patients", 
      "ResultsA total", 
      "patients", 
      "use of radiation", 
      "systematic review", 
      "literature search", 
      "cancer", 
      "chemoradiation", 
      "therapy", 
      "subtypes", 
      "present review", 
      "survival", 
      "outcomes", 
      "significant benefits", 
      "treatment", 
      "review", 
      "pancreaticoduodenectomy", 
      "chemotherapy", 
      "study", 
      "tumors", 
      "PubMed", 
      "trials", 
      "months", 
      "BackgroundGiven", 
      "total", 
      "IIb", 
      "toxicity", 
      "benefits", 
      "evidence", 
      "management", 
      "records", 
      "life", 
      "lack", 
      "nodes", 
      "search", 
      "use", 
      "data", 
      "quality", 
      "margin", 
      "radiation", 
      "observations", 
      "materials", 
      "approach", 
      "topic", 
      "best adjuvant approach", 
      "true ampullary cancer", 
      "true ampullary cancer patients"
    ], 
    "name": "Adjuvant therapy for true ampullary cancer: a systematic review", 
    "pagination": "1407-1413", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124031663"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12094-019-02278-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "31927720"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12094-019-02278-6", 
      "https://app.dimensions.ai/details/publication/pub.1124031663"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_848.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12094-019-02278-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12094-019-02278-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12094-019-02278-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12094-019-02278-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12094-019-02278-6'


 

This table displays all metadata directly associated to this object as RDF triples.

252 TRIPLES      22 PREDICATES      115 URIs      100 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12094-019-02278-6 schema:about N4273c92435db4a7b99758ac08669b884
2 N615d408c5802423688f64f096984803c
3 N62799be569114b049178f99cb96ae71d
4 N6a46285d5c3c4c8c9cc9db86f8ac8e26
5 N7201b6511a6d455fb1a9e89222d8dfd7
6 N7d8dfc15df68460a9fe8b0038e7bd575
7 N9154249c905845eda4fc412d3d62bc13
8 N9825f4b2d1284375878bd9633e1a91e7
9 Na75039ce1d4a40068f87e0df3f984cd0
10 Na7dd33e205c84e70a9248615fd9cae77
11 Nacd110784d1f40b0a5deb5db2d71bd94
12 Nb1eba7d323634814b76ee0b8749c5819
13 Ncc4351e12029412d873d618f1e092b4b
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nc8712e5d7be94d76a16cd76ca6f68497
17 schema:citation sg:pub.10.1007/s11605-011-1518-6
18 sg:pub.10.1007/s11605-017-3624-6
19 sg:pub.10.1007/s12094-018-1832-5
20 sg:pub.10.1007/s12094-018-1849-9
21 sg:pub.10.1038/bjc.2015.172
22 sg:pub.10.1186/1748-717x-6-126
23 sg:pub.10.1245/s10434-011-2117-1
24 schema:datePublished 2020-01-11
25 schema:datePublishedReg 2020-01-11
26 schema:description BackgroundGiven the lack of evidence on the best adjuvant approach, this review closely examines optimal adjuvant management for resected true ampullary cancer and its histological subtypes.Materials and methodsA comprehensive literature search of PubMed was performed to identify studies on resected true ampullary cancers, published between January 2010 and December 2018. Data including the use of radiation, chemotherapy or chemoradiation and the outcomes were extracted.ResultsA total of 116 records were identified, of which 65 screened were selected. Finally, nine studies were included. Only two of the studies reported separately the outcomes of pancreatobiliary and intestinal subtypes. Patients in the selected studies were treated with a pancreaticoduodenectomy with negative margins. Patients treated with adjuvant therapy were more likely to be pT3-4 and have positive nodes; median survival ranged from 30 to 47 months. A significant benefit for adjuvant treatment was observed in four of the studies, restricted to patients at stage IIB or higher. Likewise, patients with positive nodes may have a longer median survival with adjuvant chemoradiation compared to observation.ConclusionsThe present review suggests a benefit for adjuvant treatment for patients with locally advanced tumors. Randomized trials are needed to ascertain the topic, as well as studies reporting toxicity and quality of life of resected true ampullary cancer patients.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N247d5f3073864e5280f29b8d748c5de5
31 Na6e08cbc89e34a2f955ce802ad1af7dc
32 sg:journal.1035367
33 schema:keywords BackgroundGiven
34 ConclusionsThe present review
35 IIb
36 PubMed
37 ResultsA total
38 adjuvant approach
39 adjuvant chemoradiation
40 adjuvant management
41 adjuvant therapy
42 adjuvant treatment
43 advanced tumors
44 ampullary cancer
45 ampullary cancer patients
46 approach
47 benefits
48 best adjuvant approach
49 cancer
50 cancer patients
51 chemoradiation
52 chemotherapy
53 comprehensive literature search
54 data
55 evidence
56 histological subtypes
57 intestinal subtype
58 lack
59 lack of evidence
60 life
61 literature search
62 management
63 margin
64 materials
65 median survival
66 methodsA comprehensive literature search
67 months
68 negative margins
69 nodes
70 observations
71 optimal adjuvant management
72 outcomes
73 pT3-4
74 pancreaticoduodenectomy
75 patients
76 positive nodes
77 present review
78 quality
79 quality of life
80 radiation
81 randomized trials
82 records
83 review
84 search
85 significant benefits
86 stage IIB
87 study
88 subtypes
89 survival
90 systematic review
91 therapy
92 topic
93 total
94 toxicity
95 treatment
96 trials
97 true ampullary cancer
98 true ampullary cancer patients
99 tumors
100 use
101 use of radiation
102 schema:name Adjuvant therapy for true ampullary cancer: a systematic review
103 schema:pagination 1407-1413
104 schema:productId N192e6749f67f4a8db71c7bfb5a9fb1bd
105 N75b72b99cf6d4fd3a047552e8e55cd53
106 Na01928fe89c441a3a15e635970ef8203
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124031663
108 https://doi.org/10.1007/s12094-019-02278-6
109 schema:sdDatePublished 2022-01-01T18:57
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher N7175befcb7034c9785dc72671feede08
112 schema:url https://doi.org/10.1007/s12094-019-02278-6
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N192e6749f67f4a8db71c7bfb5a9fb1bd schema:name doi
117 schema:value 10.1007/s12094-019-02278-6
118 rdf:type schema:PropertyValue
119 N247d5f3073864e5280f29b8d748c5de5 schema:volumeNumber 22
120 rdf:type schema:PublicationVolume
121 N4273c92435db4a7b99758ac08669b884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Chemotherapy, Adjuvant
123 rdf:type schema:DefinedTerm
124 N5486f09fa5a848ef9dc7d44be00ca5b4 rdf:first sg:person.01234630226.78
125 rdf:rest rdf:nil
126 N615d408c5802423688f64f096984803c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Carcinoma, Pancreatic Ductal
128 rdf:type schema:DefinedTerm
129 N62799be569114b049178f99cb96ae71d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Treatment Outcome
131 rdf:type schema:DefinedTerm
132 N6a46285d5c3c4c8c9cc9db86f8ac8e26 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Chemoradiotherapy, Adjuvant
134 rdf:type schema:DefinedTerm
135 N7175befcb7034c9785dc72671feede08 schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 N7201b6511a6d455fb1a9e89222d8dfd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Humans
139 rdf:type schema:DefinedTerm
140 N75b72b99cf6d4fd3a047552e8e55cd53 schema:name pubmed_id
141 schema:value 31927720
142 rdf:type schema:PropertyValue
143 N7a5b9192c9094312ba50ed7bd9132cbe rdf:first Nd17a652c743b432f99a5b5153912bc7e
144 rdf:rest Neb440f2e5fd342e3b32341d1063a44bc
145 N7d8dfc15df68460a9fe8b0038e7bd575 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Pancreaticoduodenectomy
147 rdf:type schema:DefinedTerm
148 N9154249c905845eda4fc412d3d62bc13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Carcinoma
150 rdf:type schema:DefinedTerm
151 N9825f4b2d1284375878bd9633e1a91e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Duodenal Neoplasms
153 rdf:type schema:DefinedTerm
154 Na01928fe89c441a3a15e635970ef8203 schema:name dimensions_id
155 schema:value pub.1124031663
156 rdf:type schema:PropertyValue
157 Na6e08cbc89e34a2f955ce802ad1af7dc schema:issueNumber 8
158 rdf:type schema:PublicationIssue
159 Na75039ce1d4a40068f87e0df3f984cd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Adenocarcinoma
161 rdf:type schema:DefinedTerm
162 Na7dd33e205c84e70a9248615fd9cae77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Common Bile Duct Neoplasms
164 rdf:type schema:DefinedTerm
165 Nacd110784d1f40b0a5deb5db2d71bd94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Radiotherapy, Adjuvant
167 rdf:type schema:DefinedTerm
168 Nafdacd5b1de645cf9d47050cdc563ca3 rdf:first sg:person.013046075203.43
169 rdf:rest N7a5b9192c9094312ba50ed7bd9132cbe
170 Nb1eba7d323634814b76ee0b8749c5819 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Ampulla of Vater
172 rdf:type schema:DefinedTerm
173 Nc8712e5d7be94d76a16cd76ca6f68497 rdf:first sg:person.01057361501.79
174 rdf:rest Nf10a41695e95472fae7899c4e216e2ec
175 Ncc4351e12029412d873d618f1e092b4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Retrospective Studies
177 rdf:type schema:DefinedTerm
178 Nd17a652c743b432f99a5b5153912bc7e schema:affiliation grid-institutes:grid.411443.7
179 schema:familyName Carrizo
180 schema:givenName V.
181 rdf:type schema:Person
182 Neb440f2e5fd342e3b32341d1063a44bc rdf:first sg:person.0620130305.25
183 rdf:rest N5486f09fa5a848ef9dc7d44be00ca5b4
184 Nf10a41695e95472fae7899c4e216e2ec rdf:first sg:person.016462672040.21
185 rdf:rest Nafdacd5b1de645cf9d47050cdc563ca3
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
190 schema:name Oncology and Carcinogenesis
191 rdf:type schema:DefinedTerm
192 sg:journal.1035367 schema:issn 1699-048X
193 1699-3055
194 schema:name Clinical and Translational Oncology
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01057361501.79 schema:affiliation grid-institutes:grid.411443.7
198 schema:familyName Bonet
199 schema:givenName M.
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057361501.79
201 rdf:type schema:Person
202 sg:person.01234630226.78 schema:affiliation grid-institutes:grid.420395.9
203 schema:familyName Mira
204 schema:givenName M.
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234630226.78
206 rdf:type schema:Person
207 sg:person.013046075203.43 schema:affiliation grid-institutes:grid.411443.7
208 schema:familyName Vázquez
209 schema:givenName S.
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013046075203.43
211 rdf:type schema:Person
212 sg:person.016462672040.21 schema:affiliation grid-institutes:grid.411443.7
213 schema:familyName Rodrigo
214 schema:givenName A.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016462672040.21
216 rdf:type schema:Person
217 sg:person.0620130305.25 schema:affiliation grid-institutes:grid.420395.9
218 schema:familyName Vilardell
219 schema:givenName F.
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0620130305.25
221 rdf:type schema:Person
222 sg:pub.10.1007/s11605-011-1518-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040979791
223 https://doi.org/10.1007/s11605-011-1518-6
224 rdf:type schema:CreativeWork
225 sg:pub.10.1007/s11605-017-3624-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092633517
226 https://doi.org/10.1007/s11605-017-3624-6
227 rdf:type schema:CreativeWork
228 sg:pub.10.1007/s12094-018-1832-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100403978
229 https://doi.org/10.1007/s12094-018-1832-5
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s12094-018-1849-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101294118
232 https://doi.org/10.1007/s12094-018-1849-9
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/bjc.2015.172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011981731
235 https://doi.org/10.1038/bjc.2015.172
236 rdf:type schema:CreativeWork
237 sg:pub.10.1186/1748-717x-6-126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030603557
238 https://doi.org/10.1186/1748-717x-6-126
239 rdf:type schema:CreativeWork
240 sg:pub.10.1245/s10434-011-2117-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046708404
241 https://doi.org/10.1245/s10434-011-2117-1
242 rdf:type schema:CreativeWork
243 grid-institutes:grid.411443.7 schema:alternateName Department of Medical Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Lleida, Spain
244 Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain
245 schema:name Department of Medical Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Lleida, Spain
246 Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain
247 rdf:type schema:Organization
248 grid-institutes:grid.420395.9 schema:alternateName Institut de Recerca Biomèdica de Lleida (IRB-Lleida), Lleida, Spain
249 schema:name Department of Radiation Oncology, Hospital Univesitari Arnau de Vilanova (HUAV), Av. Alcalde Rovira Roure, 80, 25198, Lleida, Spain
250 Department of Surgical Pathology, Hospital Universitari Arnau de Vilanova (HUAV), Lleida, Spain
251 Institut de Recerca Biomèdica de Lleida (IRB-Lleida), Lleida, Spain
252 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...